Yanagisawa, Takafumi http://orcid.org/0000-0002-7410-0712
Mori, Keiichiro
Katayama, Satoshi
Mostafaei, Hadi
Quhal, Fahad
Laukhtina, Ekaterina
Rajwa, Pawel
Motlagh, Reza Sari
Aydh, Abdulmajeed
König, Frederik
Grossmann, Nico C.
Pradere, Benjamin
Miki, Jun
Kimura, Takahiro
Egawa, Shin
Shariat, Shahrokh F.
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 4 August 2021
Accepted: 20 October 2021
First Online: 10 November 2021
Declarations
:
: Shin Egawa is a paid consultant/advisor of Takeda, Astellas, AstraZeneca, Sanofi, Janssen, and Pfizer. Takahiro Kimura is a paid consultant/advisor of Astellas, Bayer, Janssen and Sanofi. Shahrokh F. Shariat is a paid as follows: Honoraria: Astellas, AstraZeneca, Bayer, BMS, Cepheid, Ferring, Ipsen, Janssen, Lilly, MSD, Olympus, Pfizer, Pierre Fabre, Richard Wolf, Roche, Sanochemia, Sanofi, Takeda, Urogen. Consulting or Advisory Role: Astellas, AstraZeneca, Bayer, BMS, Cepheid, Ferring, Ipsen, Janssen, Lilly, MSD, Olympus, Pfizer, Pierre Fabre, Richard Wolf, Roche, Sanochemia, Sanofi, Takeda, Urogen. Speakers Bureau: Astellas, Astra Zeneca, Bayer, BMS, Cepheid, Ferring, Ipsen, Janssen, Lilly, MSD, Olympus, Pfizer, Pierre Fabre, Richard Wolf, Roche, Sanochemia, Sanofi, Takeda, Urogen, Movember Foundation. The other authors declare no conflicts of interest associated with this manuscript.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.